Tampa, United States
Research view
Mantle cell lymphoma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- CD19 20
- BTK 17
- CD20 8
- TP53 2
- BCL-2 5
- PI3K 0
- CD22 3
- MYC 0
- PD-1 2
- CXCR4 0
- EGFR 0
- PD-L1 1
- PRMT5 0
- ALK 0
- CD47 0
- JAK 0
- STAT3 0
- AKT 0
- ATM 0
- BRCA1 1
- BRCA2 1
- BRD4 0
- CCR5 0
- CD40 0
- FLT3 0
- GPX4 0
- HDAC 0
- HSP90 0
- KMT2A 0
- MET 0
- mTOR 0
EU-13 is a filter, not a ranking: it only narrows the list.
Beijing, China
Milan, Italy
Chengdu, China
Barcelona, Spain
Rome, Italy
Milan, Italy
Paris, France
Suzhou, China
Madrid, Spain
Essen, Germany
Aalborg, Denmark
Créteil, France
13 of 13+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Withdrawn
“business decision; no enrolled patients”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.